Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ciliberto

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
Journal of Virology|April 25, 2000
Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitisL Aurisicchio, P Delmastro, V Salucci, et al.
The EMBO Journal|December 15, 1994
Rational design of a receptor super-antagonist of human interleukin-6R Savino, L Ciapponi, A Lahm, et al.
The American Journal of Pathology|August 26, 1998
Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic miceP Schirmacher, M Peters, G Ciliberto, et al.
The European Journal of Neuroscience|April 24, 1999
Presence of a reduced opioid response in interleukin-6 knock out miceM Bianchi, R Maggi, F Pimpinelli, et al.
The Journal of Clinical Investigation|February 15, 1997
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammationF De Benedetti, T Alonzi, A Moretta, et al.
Human Gene Therapy|September 15, 2000
Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failureG Rizzuto, M Cappelletti, C Mennuni, et al.
The EMBO Journal|March 1, 1994
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletionV Poli, R Balena, E Fattori, et al.
The EMBO Journal|March 15, 1994
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationR Savino, A Lahm, A L Salvati, et al.
European Journal of Biochemistry|January 15, 1993
Structural characterization of a biologically active human lipocortin 1 expressed in Escherichia coliR Arcone, G Arpaia, M Ruoppolo, et al.
The EMBO Journal|June 3, 1996
Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivityC Toniatti, A Cabibbo, E Sporena, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Journal of Virology|April 25, 2000
Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitisL Aurisicchio, P Delmastro, V Salucci, et al.
The EMBO Journal|December 15, 1994
Rational design of a receptor super-antagonist of human interleukin-6R Savino, L Ciapponi, A Lahm, et al.
The American Journal of Pathology|August 26, 1998
Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic miceP Schirmacher, M Peters, G Ciliberto, et al.
The European Journal of Neuroscience|April 24, 1999
Presence of a reduced opioid response in interleukin-6 knock out miceM Bianchi, R Maggi, F Pimpinelli, et al.
The Journal of Clinical Investigation|February 15, 1997
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammationF De Benedetti, T Alonzi, A Moretta, et al.
Human Gene Therapy|September 15, 2000
Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failureG Rizzuto, M Cappelletti, C Mennuni, et al.
The EMBO Journal|March 1, 1994
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletionV Poli, R Balena, E Fattori, et al.
The EMBO Journal|March 15, 1994
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationR Savino, A Lahm, A L Salvati, et al.
European Journal of Biochemistry|January 15, 1993
Structural characterization of a biologically active human lipocortin 1 expressed in Escherichia coliR Arcone, G Arpaia, M Ruoppolo, et al.
The EMBO Journal|June 3, 1996
Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivityC Toniatti, A Cabibbo, E Sporena, et al.
Pageof 16